Navigation Links
Reportlinker Adds Retinal Vein Occlusion (RVO) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Date:5/24/2011

29.25% between 2005 and 2010. Until the market entry of Lucentis (ranibizumab) in 2006, the RVO therapeutics market was growing at a lower rate. After the entry of Lucentis, the market registered a growth rate of 40.13% between 2006 and 2007. Up until now, Lucentis and Ozurdex have been the only approved drugs for the treatment of RVO. The late-stage clinical development pipeline consists of 50% first-in-class and 50% me-too drugs that are effective and safe for RVO patients. Once these drugs enter the market, the market will grow further at a significant rate. Therefore, GlobalData estimates that the RVO therapeutics market in 2017 will be $1.4 billion, indicating a Compound Annual Growth Rate (CAGR) of 16.08% between 2010 and 2017

Scope

The report provides information on the key drivers and challenges of the retinal vein occlusion therapeutics market. Its scope includes -

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) retinal vein occlusion therapeutics market revenues data from 2005 to 2010, forecast for seven years to 2017.

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes such as VEGF inhibitors, HMG CoA reductase inhibitors, Glucocorticoid receptor agonists, and kallikrein inhibitors.

- Analysis of the current and future competition in the seven key countries retinal vein occlusion market. Key market players covered are Allergan, Inc., Alimera Sciences, Icon Biosciences, and Regeneron Pharmaceuticals.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the retinal vein occlusion
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
2. Reportlinker Adds Triple Analysis: Lymphoma, Melanoma and Peptides
3. Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides
4. Reportlinker Adds Advanced Digital Medical Equipment Products Market
5. Reportlinker Adds India Medical Devices Manufacturers, Distributors and Exporters Directory 2011
6. Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
7. Reportlinker Adds Orphan Drugs in Asia 2011
8. Reportlinker Adds Global Water Market Outlook: Strategic Analysis of Water and Wastewater Management in the Pharmaceutical Industry
9. Reportlinker Adds The Outlook for Medical Devices in South East Asia
10. Reportlinker Adds Pharmaceutical Management of Obesity (Technical Insights)
11. Reportlinker Adds Machine-to-Machine (M2M) Communications in Healthcare 2010-20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... all-time hits leader, is the new spokesperson for the topical ... announced. "Pete,s a Hall of Famer in our ... with Myoflex," said Ducere Pharma Chief Executive Officer Chris ... across all generations. The passion and intensity that Pete brought ...
(Date:1/23/2015)... VEGAS , Jan. 23, 2015 Cord Blood America, ... ) ("CBAI" or the "Company")  filed a Preliminary Proxy Statement, ... www.sec.gov ) today, and provides an update for shareholders detailing ... shares is requested. Dear Shareholders, As ...
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... and development company, is delighted to announce that the ... to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for the ...
Breaking Medicine Technology:Pete Rose bets on Myoflex to relieve aches and pains 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
(Date:1/22/2015)... 22, 2015 A study recently ... flagship journal Medicine & Science in Sports & ... may help reduce gastrointestinal (GI) problems associated with ... Participants in the double-blind, placebo-controlled study took 10 ...
(Date:1/22/2015)... Weddingshe.com has added many trendy Champagne wedding dresses ... in the past three years. Today, the business announces a ... to the sales manager of the company, this is on ... This point can be reflected on the discounted wedding dresses ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Four years since the ... – which coincided with the marriage of Avasa & Matthew Love ... ROAD, which is scheduled for release through White Swan Records on ... that there is a sacred path available to all of us ...
(Date:1/22/2015)... 22, 2015 EBSCO Information Services ... expanding their relationship in an effort to further promote visibility ... While EBSCO has long made AMA journals available via its ... for The JAMA Network. , Long known as ...
(Date:1/22/2015)... 22, 2015 JJsHouse.com is a famous dress ... the business announces its latest collection of wedding dresses ... most important issue is the wedding dress on your big ... a woman’s life. Every bride wants to find the most ...
Breaking Medicine News(10 mins):Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... published research in the April 9 issue of Archives ... cocoa are beneficial// in reducing blood pressure, instead of ... guidelines advise individuals with hypertension (high blood pressure) to ... in the article. Compounds known as polyphenols or flavonoids ...
... has another new risk- it heightens your chances of developing ... in fact set you on the road to Alzheimer’s. ... of Archives of Neurology, one of the JAMA/Archives journals. ... been consistently related to a higher risk of Alzheimer's disease," ...
... Novartis case, the government of India is moving fast to ... has now been notified that all patent litigations filed in ... Patent Act have been transferred to the Intellectual Property Appellate ... companies have filed cases in High Courts and lower courts ...
... to data released by Banfield, The Pet Hospital, one of ... 39,000 cats and dogs// were sickened or killed nationwide consequent ... ,The data was reportedly compiled from records collected from more ... massive recall of contaminated pet food. Described as one of ...
... (TYC) facilities continue to reel under allegations of ward neglect ... about the agency. , Leaders of the state ... juvenile inmates, as well as gross neglect of their health. ... had to wait up to even months before they were ...
... of hepatitis B patients, said an official of the ... 500,000 people die of liver damage and hepatocirrhosis triggered ... ,He said about 120 million Chinese test ... health problem in the country. ,HPF and ...
Cached Medicine News:Health News:Blood Pressure Tackled Better With Cocoa Than Tea 2Health News:Diabetes May Bring You A Step Closer To Alzheimer’s Diseas 2Health News:Patents: Appellate Board Becomes Functional 2Health News:Melamine Contamination Killed Thousands of Pets, Says a New Report 2
Clearview RSV is a simple, immunochromatographic assay to aid in the diagnosis of respiratory syncytial virus (RSV) infections in children less than 6 years and adults over age 60....
... one of the easiest tests to run on ... 15 minutes with no hands-on time. Critical care ... the child leaving the pediatrician's office and valuable ... to help control the spread of RSV infections. ...
For the qualitative detection of IgG/IgM antibodies to B. burgdorferi...
... Experience the finest surgical-quality loupes ... set the standard for innovative optical ... support. Delivering optimum performance with maximum ... choice for medical professionals worldwide. Make ...
Medicine Products: